These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4248216)

  • 1. Niacin and the schizophrenic patient.
    Newbold HL; Mosher LR
    Am J Psychiatry; 1970 Oct; 127(4):535-6. PubMed ID: 4248216
    [No Abstract]   [Full Text] [Related]  

  • 2. Nicotinic acid in the treatment of schizophrenia.
    Med Lett Drugs Ther; 1973 Dec; 15(26):107-8. PubMed ID: 4271841
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemistry of nicotinic acid and nicotinamide.
    Hoffer A
    Psychosomatics; 1967; 8(2):95-100. PubMed ID: 4227744
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse effects of niacin in emergent psychosis.
    Heninger GR; Bowers MB
    JAMA; 1968 Jun; 204(11):1010-1. PubMed ID: 4231749
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of nicotinic acid on the frequency and duration of re-hospitalization of schizophrenic patients; a controlled comparison study.
    Hoffer A
    Int J Neuropsychiatry; 1966 Jun; 2(3):234-40. PubMed ID: 4225426
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolic response of humans to ingestion of nicotinic acid and nicotinamide.
    Mrochek JE; Jolley RL; Young DS; Turner WJ
    Clin Chem; 1976 Nov; 22(11):1821-7. PubMed ID: 135660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nicotinic acid and nicotinamide adenine dinucleotide (NAD) therapy in schizophrenia: a review.
    Wittkopp TA; Abuzzahab FS
    Behav Neuropsychiatry; 1972; 4(7-8):6-12. PubMed ID: 4348727
    [No Abstract]   [Full Text] [Related]  

  • 8. Nicotinic acid in the treatment of newly admitted schizophrenic patients: a placebo-controlled study.
    Ananth JV; Vacaflor L; Kekhwa G; Sterlin C; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):406-10. PubMed ID: 4261601
    [No Abstract]   [Full Text] [Related]  

  • 9. Niacin in the long-term treatment of schizophrenia.
    Wittenborn JR; Weber ES; Brown M
    Arch Gen Psychiatry; 1973 Mar; 28(3):308-15. PubMed ID: 4569673
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of nicotinic acid and pyridoxine in the treatment of schizophrenia.
    Petrie WM; Ban TA; Ananth JV
    Int Pharmacopsychiatry; 1981; 16(4):245-50. PubMed ID: 7040274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinic acid in the treatment of chronic hospitalized schizophrenic patients: a placebo-controlled clinical study.
    Deutsch M; Ananth JV; Ban TA
    Psychopharmacol Bull; 1977 Jul; 13(3):21-3. PubMed ID: 142260
    [No Abstract]   [Full Text] [Related]  

  • 12. [Traffic hazards due to INH therapy and other drugs from the viewpoint of the dermatologist].
    EHRING F
    Med Klin; 1955 Jun; 50(23):979-80. PubMed ID: 14393440
    [No Abstract]   [Full Text] [Related]  

  • 13. Adverse effects of niacin in emergent psychosis.
    Hoffer A
    JAMA; 1969 Feb; 207(7):1355. PubMed ID: 4885414
    [No Abstract]   [Full Text] [Related]  

  • 14. A chemical treatment for schizophrenia.
    Alvarez WC
    Geriatrics; 1967 Mar; 22(3):111-2. PubMed ID: 4225316
    [No Abstract]   [Full Text] [Related]  

  • 15. Pigmented hyperkeratosis among schizophrenic patients treated with nicotinic acid.
    Wittenborn JR; Nenno R; Rothberg H; Shelley WB
    Adv Biochem Psychopharmacol; 1974; 9(0):295-300. PubMed ID: 4151765
    [No Abstract]   [Full Text] [Related]  

  • 16. [Formation of nicotinamide from nicotinic acid in the rat liver].
    Khalmuradov AG; Shushevich SI; Fomenko GI
    Ukr Biokhim Zh; 1971; 43(5):566-71. PubMed ID: 4263256
    [No Abstract]   [Full Text] [Related]  

  • 17. Acanthosis nigricans and nicotinic acid.
    Elgart ML
    J Am Acad Dermatol; 1981 Dec; 5(6):709-10. PubMed ID: 7320272
    [No Abstract]   [Full Text] [Related]  

  • 18. Nicotinic acid and nicotinamide in the treatment of chronic schizophrenia.
    Vallely JF; Lovegrove TD; Hobbs GE
    Can Psychiatr Assoc J; 1971 Oct; 16(5):433-5. PubMed ID: 4261335
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of niacin in emergent psychosis.
    Heninger GR; Bowers JB
    JAMA; 1969 Feb; 207(7):1355. PubMed ID: 4885415
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotinic acid therapy in chronic schizophrenia.
    Sehdev HS; Olson JL
    Compr Psychiatry; 1974; 15(6):511-7. PubMed ID: 4609684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.